<DOC>
	<DOCNO>NCT00947102</DOCNO>
	<brief_summary>Observational study influence gemcitabine treatment serological immunological status gene expression profile patient pancreatic tubular carcinoma tumor resection .</brief_summary>
	<brief_title>Influence Gemcitabine Treatment Immunological Serological Profile Patients With Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>ECOG performance status 02 time inclusion Following R0 R1 pancreatic tubular adenocarcinoma resection Pregnancy Serious comorbidity</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>pancreatic tubular adenocarcinoma</keyword>
	<keyword>gemcitabine</keyword>
	<keyword>gene expression</keyword>
	<keyword>immunological status</keyword>
	<keyword>serological status</keyword>
	<keyword>pancreatic tubular adenocarcinoma adjuvant set</keyword>
</DOC>